Kong Lingling, Yang Nianzhao, Shi Lianghui, Zhao Guohai, Wang Minghai, Zhang Yisheng
Department of General Surgery, The First Affiliated Yijishan Hospital of Wannan Medical College, Wuhu, People's Republic of China.
Onco Targets Ther. 2016 Nov 7;9:6795-6800. doi: 10.2147/OTT.S110828. eCollection 2016.
This meta-analysis of randomized controlled trials was conducted to give a more precise estimation of the efficacy and drawbacks of total gastrectomy (TG) versus subtotal gastrectomy (SG) for proven distal gastric cancer.
The electronic databases Cochrane and PubMed (updated on April 10, 2016) were searched for randomized controlled trials comparing TG with SG as surgical procedures for distal gastric cancer. Five outcome variables were analyzed, including postoperative complications, anastomotic fistula rate, hospital mortality rate, mortality rate of recurrence (the patient's death is caused by the recurrence of gastric cancer, rather than caused by other diseases), and 5-year survival rate. Random or fixed effect model was used to perform this meta-analysis.
Six trials, including 573 cases treated with TG and 791 cases treated with SG, were included. Compared with patients in the SG group, patients in the TG group did not show a higher rate of postoperative complications (odds ratio [OR]: 1.46, 95% confidence interval [CI]: 0.71-3.03, =0.30). However, patients in the TG group showed a significantly higher rate of anastomotic fistula than patients in the SG group (OR: 3.78, 95% CI: 1.97-7.27, <0.0001). Hospital mortality rate, which was analyzed in four trials, including 510 TG versus 729 SG patients, showed no significant difference between the two groups (OR: 1.80, 95% CI: 0.85-3.78, =0.12). Importantly, there was no significant difference in the 5-year survival between the two groups (OR: 0.68, 95% CI: 0.39-1.19, =0.18). Mortality rate of recurrence, which was also analyzed in three trials, including 396 TG versus 407 SG patients, showed a significantly higher rate in the TG group (OR: 0.07, 95% CI: 0.01-0.13, =0.03).
This meta-analysis demonstrated that postoperative complications, hospital mortality rate, and 5-year survival rate in TG patients was similar to the SG group. Furthermore, SG was associated with significantly fewer anastomotic fistula and lower mortality rate of recurrence compared with TG. However, lower mortality rate of recurrence was probably related to the criteria of these two procedures.
本随机对照试验的荟萃分析旨在更精确地评估全胃切除术(TG)与胃次全切除术(SG)治疗确诊远端胃癌的疗效和缺点。
检索电子数据库Cochrane和PubMed(2016年4月10日更新),查找比较TG与SG作为远端胃癌手术方法的随机对照试验。分析了五个结局变量,包括术后并发症、吻合口瘘发生率、医院死亡率、复发死亡率(患者死亡由胃癌复发引起,而非其他疾病所致)和5年生存率。采用随机或固定效应模型进行此荟萃分析。
纳入六项试验,其中TG治疗573例,SG治疗791例。与SG组患者相比,TG组患者术后并发症发生率未更高(优势比[OR]:1.46,95%置信区间[CI]:0.71 - 3.03,P = 0.30)。然而,TG组患者吻合口瘘发生率显著高于SG组患者(OR:3.78,95% CI:1.97 - 7.27,P < 0.0001)。在四项试验中分析的医院死亡率,其中TG患者510例,SG患者729例,两组间无显著差异(OR:1.80,95% CI:0.85 - 3.78,P = 0.12)。重要的是,两组间5年生存率无显著差异(OR:0.68,95% CI:0.39 - 1.19,P = 0.18)。在三项试验中也分析了复发死亡率,其中TG患者396例,SG患者407例,TG组复发死亡率显著更高(OR:0.07,95% CI:0.01 - 0.13,P = 0.03)。
本荟萃分析表明,TG患者的术后并发症、医院死亡率和5年生存率与SG组相似。此外,与TG相比,SG吻合口瘘显著更少,复发死亡率更低。然而,较低的复发死亡率可能与这两种手术的标准有关。